Log in to save to my catalogue

STADE‐HF (sST2 As a help for management of HF): a pilot study

STADE‐HF (sST2 As a help for management of HF): a pilot study

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_92f113b384284cfc9e365d6c9500379c

STADE‐HF (sST2 As a help for management of HF): a pilot study

About this item

Publication information

Publisher

England: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Aims
Biomarkers are not recommended until now to guide the management of patients with heart failure (HF). Soluble suppression of tumorigenicity 2 (sST2) appears as a promising biomarker. The current study considered pre‐discharged sST2 values as a guide for medical management in patients admitted for acute HF decompensation, in an attempt to re...

Alternative Titles

Full title

STADE‐HF (sST2 As a help for management of HF): a pilot study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_92f113b384284cfc9e365d6c9500379c

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_92f113b384284cfc9e365d6c9500379c

Other Identifiers

ISSN

2055-5822

E-ISSN

2055-5822

DOI

10.1002/ehf2.12663

How to access this item